Botox® in urology-will it become standard of care for urge urinary incontinence?

Journal of Urology

Volumn 184, Issue 6, 2010, Pages 2235-2236

  Smith, Christopher P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; MUSCARINIC RECEPTOR BLOCKING AGENT; PLACEBO;

CLINICAL TRIAL; DRUG COST; DRUG EFFICACY; EDITORIAL; HEALTH CARE COST; HUMAN; OVERACTIVE BLADDER; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; URGE INCONTINENCE; UROLOGY;

BOTULINUM TOXINS, TYPE A; HUMANS; URINARY INCONTINENCE, URGE;

EID: 78349313814     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.09.050     Document Type: Editorial

References (9)

1. J.T. Anger, A. Weinberg, and M.J. Suttorp Outcomes of intravesical botulinum toxin for idiopathic overactive bladder symptoms: a systematic review of the literature J Urol 183 2010 2258
2. B. Schurch, M. deSze, and P. Denys Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study J Urol 174 2005 196
3. M.B. Chancellor, C.J. Fowler, and A. Apostolidis Drug insight: biological effects of botulinum toxin A in the lower urinary tract Nat Clin Pract Urol 5 2008 319
4. C.R. Chapple, V. Khullar, and Z. Gabriel The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis Eur Urol 54 2008 543
5. T.W. Hu, T.H. Wagner, and J.D. Bentkover Estimated economic costs of overactive bladder in the United States Urology 61 2003 1123
6. J.M. Wu, N.Y. Siddiqui, and C.L. Amundsen Cost-effectiveness of botulinum toxin A versus anticholinergic medications for idiopathic urge incontinence J Urol 181 2009 2181
7. J.H. Watanabe, J.D. Campbell, and A. Ravelo Cost analysis of interventions for antimuscarinic refractory patients with overactive bladder Urology 2010 Epub ahead of print
8. A. Wagg, C. Verdejo, and U. Molander Review of cognitive impairment with antimuscarinic agents in elderly patients with overactive bladder Int J Clin Pract 64 2010 1279
9. Y.C. Chuang, P. Tyagi, and C.C. Huang Urodynamic and immunohistochemical evaluation of intravesical botulinum toxin A delivery using liposomes J Urol 182 2009 786